List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 162 studies with search of: "Rhabdomyosarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Vaccine Therapy and Interleukin-2 With or Without White Blood Cell Transplantation in Treating Patients With Recurrent Sarcomas
Conditions: Recurrent Childhood Rhabdomyosarcoma;   Extraosseous Ewing's Sarcoma/Primitive Neuroectodermal Tumor;   Recurrent Ewing's Sarcoma/Primitive Neuroectodermal Tumor;   Adult Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Alveolar Childhood Rhabdomyosarcoma;   Recurrent Tumors of the Ewing's Family;   Recurrent Adult Soft Tissue Sarcoma
Intervention: Drug: interleukin-2
2 Recruiting Proton RT for the Treatment of Pediatric Rhabdomyosarcoma
Condition: Rhabdomyosarcoma
Intervention: Radiation: Proton Beam Radiation
3 Completed New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma
Conditions: Ewing's Sarcoma;   Neuroblastoma;   Rhabdomyosarcoma
Interventions: Drug: ADR-529;   Drug: Topotecan;   Drug: G-CSF
4 Terminated Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
Conditions: Rhabdomyosarcoma;   Malignant Soft Tissue
Intervention: Drug: Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide
5 Not yet recruiting EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
Condition: Rhabdomyosarcoma
Intervention: Drug: doxorubicin, cytoxan
6 Not yet recruiting Trial for Localised High-Risk Rhabdomyosarcoma and Rhabdomyosarcoma-Like Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: trofosfamide, idarubicin, etoposide
7 Active, not recruiting Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors
Conditions: Tumors;   Brain Tumors;   Rhabdomyosarcoma;   Sarcoma, Soft Tissue
Intervention: Drug: Everolimus
8 Recruiting Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: vincristine sulfate
9 Recruiting Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Radiation: radiation therapy
10 Completed Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
Conditions: Cancer-Related Problem/Condition;   Sarcoma
Interventions: Procedure: management of therapy complications;   Procedure: quality-of-life assessment
11 Recruiting Trial of Dasatinib in Advanced Sarcomas
Conditions: Rhabdomyosarcoma;   Malignant Peripheral Nerve Sheath Tumors;   Osteosarcoma;   Chondrosarcoma;   Sarcoma, Ewing's;   Sarcoma, Alveolar Soft Part;   Chordoma;   Epithelioid Sarcoma;   Giant Cell Tumor of Bone;   Hemangiopericytoma;   Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: Dasatinib
12 Recruiting Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Conditions: Peritoneal Neoplasms;   Retroperitoneal Neoplasms;   Gastrointestinal Neoplasms;   Adenocarcinoma;   Neuroblastoma;   Ovarian Neoplasms;   Sarcoma;   Adrenocortical Carcinoma;   Wilms Tumor;   Rhabdomyosarcoma;   Desmoplastic Small Round Cell Tumor
Interventions: Drug: CHPP of Cisplatin;   Procedure: Abdominal Surgery
13 Recruiting A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent
Conditions: Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET);   Rhabdomyosarcoma;   Leiomyosarcoma;   Adipocytic Sarcoma;   Synovial Sarcoma
Intervention: Biological: IMC-A12
14 Completed Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Biological: filgrastim;   Biological: sargramostim;   Drug: cyclophosphamide;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: surgical procedure;   Radiation: radiation therapy
15 Recruiting Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vinorelbine ditartrate;   Procedure: conventional surgery;   Radiation: radiation therapy
16 Recruiting Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: radiation therapy
17 Recruiting Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: irinotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: radiation therapy
18 Recruiting Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: irinotecan hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
19 Completed Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Biological: filgrastim;   Biological: sargramostim;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Radiation: radiation therapy
20 Active, not recruiting Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: irinotecan hydrochloride;   Drug: tirapazamine;   Drug: vincristine sulfate

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services